Inotiv Reports First Quarter Financial Results for Fiscal 2024 and Provides Business Update
February 07, 2024 16:05 ET
|
Inotiv, Inc.
- First quarter fiscal 2024 revenue up 10.3% to $135.5 million - First quarter fiscal 2024 DSA revenue up 8.8% to $44.7 million and RMS revenue up 11.1% to $90.8 million - Shift to a renewed focus...
Inotiv, Inc. to Report Fiscal 2024 First Quarter Financial Results and Host Conference Call on Wednesday, February 7, 2024
January 29, 2024 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical...
Inotiv Reports Fourth Quarter and Full Year Financial Results for Fiscal 2023 and Provides Business Update
December 11, 2023 16:05 ET
|
Inotiv, Inc.
— Fiscal year 2023 revenue up 4.5% to $572.4 million, achieving full year revised guidance— Achievements in the past fiscal year to expand DSA capacity, develop new services and reduce outsourcing...
Inotiv, Inc. Announces Plan to Insource North American Transportation Operations
December 06, 2023 16:30 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug...
Inotiv, Inc. to Report Fiscal 2023 Fourth Quarter and Full Year Results and Host Conference Call on Monday, December 11, 2023
November 27, 2023 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...
Inotiv Provides Business Updates and Upcoming Investor Conferences Update
November 13, 2023 16:05 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and...
Inotiv Ranked Number 127 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™
November 08, 2023 07:30 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Inotiv today announced it ranked 127 on the Deloitte Technology Fast 500™, a ranking of the fastest-growing technology, media,...
Inotiv, Inc. to Participate in Upcoming Investor Conferences
November 01, 2023 08:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization specializing in nonclinical and analytical drug discovery and...
Inotiv, Inc. Announces Changes to its Board Composition
October 16, 2023 08:00 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV), a leading contract research organization, today announced the appointment of Terry Coelho to its Board of...
Inotiv Announces the Sale of its Israeli Businesses to Harlan Holdings Ltd.
August 29, 2023 18:47 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., Aug. 29, 2023 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...